This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings: Archive
AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates
by Zacks Equity Research
AngioDynamics (ANGO) delivered earnings and revenue surprises of +36.36% and +7.61%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?
ANGOPositive Net Change COCHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Here's What Key Metrics Tell Us About FB Financial (FBK) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for FB Financial (FBK) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
FBKPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Is Johnson & Johnson Stock Poised for New Highs as Q2 Results Approach?
by Shaun Pruitt
After hitting fresh all-time highs last week, investors are turning their attention to JNJ's Q2 report, which is scheduled for Wednesday, July 15, before the opening bell.
JNJNegative Net Change
dividend-investing dividends earnings investing large-cap medical medical-devices oncology-screening pharmaceuticals
FB Financial (FBK) Q2 Earnings Match Estimates
by Zacks Equity Research
FB Financial (FBK) delivered earnings and revenue surprises of 0.00% and +0.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
FBKPositive Net Change OFGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Can Progressive Surpass Estimates This Earnings Season?
by Zacks Equity Research
Progressive enters Q2 earnings season with higher premiums and investment income poised to offset rising costs, and a projected year-over-year profit decline.
PGRNegative Net Change TRVNegative Net Change CBNegative Net Change ACGLNegative Net Change
earnings insurance
Will Health Benefits Weakness Drag Elevance's Q2 Earnings?
by Zacks Equity Research
ELV faces Q2 pressure as weaker Health Benefits results and higher benefit expenses may weigh on earnings ahead of its July 15 report.
ELVNegative Net Change CAHNegative Net Change ALCNegative Net Change PMNPositive Net Change
earnings insurance medical
Q2 Earnings Season Kicks Off: Global Week Ahead
by John Blank
Q2 S&P500 earnings season is kicking off with the world's largest chipmaker, and key U.S. banks reporting results, while macro-data out of the U.S. and China will give fresh perspectives.
GSPositive Net Change BACPositive Net Change WFCNegative Net Change JPMPositive Net Change MSPositive Net Change CNegative Net Change AAPLNegative Net Change AMDPositive Net Change JNJNegative Net Change BLKNegative Net Change NFLXPositive Net Change NVDAPositive Net Change CMIPositive Net Change AVGOPositive Net Change SNPSNegative Net Change TSMNegative Net Change ASXPositive Net Change SKHYPositive Net Change
earnings finance oil-energy tech-stocks
Earnings Estimates Rising for Penguin Solutions, Inc. (PENG): Will It Gain?
by Zacks Equity Research
Penguin Solutions, Inc. (PENG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
PENGNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Ategrity Specialty Insurance Company Holdings (ASIC) Could Beat Earnings Estimates Again
by Zacks Equity Research
Ategrity Specialty Insurance Company Holdings (ASIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ASICNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Brookfield (BAM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Brookfield (BAM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BAMPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate